BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue

  September 19, 2024

   · 

  6 min read
• Press Releases

  BayCare Breaks Ground on Cancer Institute Expansion to Bring Revolutionary MEVION S250-FIT Proton Therapy to Tampa

  September 19, 2024

   · 

  2 min read
• Press Releases

  Edgewise Therapeutics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM)

  September 19, 2024

   · 

  9 min read
• Press Releases

  Pharmagreen Biotech, Inc. (PHBI) Reaffirms Commitment to Non-Toxic Financing Amid Ongoing Business Development Progress

  September 19, 2024

   · 

  4 min read
• Press Releases

  Eyconis, Inc. Announces Appointment of Dr. Mark J. Bachleda as Chief Executive Officer and Member of the Board of Directors

  September 19, 2024

   · 

  4 min read
• Press Releases

  Cidara Therapeutics Strengthens its Scientific Advisory Board with Infectious Disease Experts

  September 19, 2024

   · 

  6 min read
• Press Releases

  Apnimed Announces Early Completion of Enrollment in Phase 3 SynAIRgy Study of AD109, the First Potential Oral Treatment Addressing the Neuromuscular Cause of Obstructive Sleep Apnea

  September 19, 2024

   · 

  6 min read
• Press Releases

  Lumeris Appoints Dr. David Carmouche as Executive Vice President and Chief Clinical Transformation Officer

  September 19, 2024

   · 

  3 min read
• Press Releases

  SciNeuro Pharmaceuticals to Present Preclinical Efficacy and Safety Data on SNP614, a Novel Antisense Oligonucleotide Directed to LRRK2, at the 2024 International Congress of Parkinson’s Disease and Movement Disorders

  September 19, 2024

   · 

  2 min read
• Press Releases

  Jupiter Endovascular Announces First Patients Successfully Treated in First Clinical Study of Vertex Pulmonary Embolectomy System Using Endoportal Control

  September 19, 2024

   · 

  4 min read